What sector does Ajanta Pharma Limited belong to?

Ajanta Pharma Limited operates in the Healthcare sector, specifically the Pharmaceuticals industry, and is listed on the NSE.

What is the current share price of AJANTPHARM?

As of the latest available quote, AJANTPHARM traded at ₹3,559.90. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of AJANTPHARM?

Ajanta Pharma Limited has a price-to-earnings (P/E) ratio of about 39.20. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of AJANTPHARM?

The market capitalisation of Ajanta Pharma Limited is approximately ₹44,153 Cr.

Is Ajanta Pharma Limited profitable?

For its latest reported financial year, Ajanta Pharma Limited recorded a net profit margin of about 19.37%.

Does AJANTPHARM pay a dividend?

Ajanta Pharma Limited currently has a dividend yield of about 0.80%.

What is the return on equity (ROE) of AJANTPHARM?

Ajanta Pharma Limited has a return on equity (ROE) of about 27.10%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of AJANTPHARM?

Over the past 52 weeks, AJANTPHARM has traded between a low of ₹2,329.90 and a high of ₹3,796.00.

Ajanta Pharma Limited

AJANTPHARM NSE Healthcare Pharmaceuticals

Nifty 500 Midcap 150 LargeMid 250

₹3,559.90

+1.13%

Delayed · cached 15 min

Fair value analysis

AJANTPHARM

Ajanta Pharma Limited

₹3,520.00

Close used for this calculation

₹2,506.67Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

64/100

Profitability23/25

Returns12/25

Balance Sheet21/25

Efficiency8/25

Growth12/25

Good

Quality radar

Consensus fair value

₹2,506.67

Above FV

▼ -28.8% against the close used

Model range ₹267.43 – ₹3,017.36

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₹267.43Fair value₹2,506.67Bull₹3,017.36

FairClose

52-week traded range

52W low ₹2,388.4052W high ₹3,718.20

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

Ajanta Pharma Limited closed at ₹3,520.00, 40.4% above the consensus fair value of ₹2,506.67 drawn from 8 valuation models.

Financial DNA score 64/100 — Good. P/E of 38.9x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

₹267.43

-92.4%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=9%, r=10%, tg=3%, n=10yr

Graham Number

₹858.62

-75.6%

√(22.5 × EPS × BVPS)

EPS=84.52, BVPS=387.67 · outside Graham range (P/E 38.9, P/B 9.1) — asset-light, treat as a rough floor

P/E Fair Value

₹3,017.36

-14.3%

EPS × 35.7x (sector P/E)

EPS=84.52, Sector P/E=35.7x

Peter Lynch (PEG)

₹1,910.15

-45.7%

EPS × Growth% (PEG = 1 is fair)

EPS=84.52, g=22.6%

EV/EBITDA

₹2,380.04

-32.4%

(EBITDA × 18x − Net Debt) ÷ Shares

EBITDA=16.73B

Book Value (P/B)

₹2,044.93

-41.9%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=387.67, ROE=27.1%, g=6%, r=10%

Reverse DCF

₹3,520.00

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: 17% | Historical: 22.6%

Margin of Safety

₹1,035.85

-70.6%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=1381.14, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer